Chuan Zou

427 total citations
23 papers, 316 citations indexed

About

Chuan Zou is a scholar working on Nephrology, Molecular Biology and Hematology. According to data from OpenAlex, Chuan Zou has authored 23 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Chuan Zou's work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Gut microbiota and health (5 papers). Chuan Zou is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (7 papers) and Gut microbiota and health (5 papers). Chuan Zou collaborates with scholars based in China, United States and Sweden. Chuan Zou's co-authors include Zhaoyu Lu, Xusheng Liu, Fuhua Lu, Lijuan Han, Qizhan Lin, Yuqun Zeng, Yang Chen, Zhenhua Dai, Chen Cha and Dingcheng Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BioMed Research International.

In The Last Decade

Chuan Zou

23 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuan Zou China 9 159 98 73 40 31 23 316
Yunlong Qin China 8 145 0.9× 80 0.8× 80 1.1× 14 0.3× 23 0.7× 28 283
Jessyca Sousa de Brito Brazil 8 181 1.1× 134 1.4× 96 1.3× 13 0.3× 28 0.9× 18 382
Zixian Yu China 6 126 0.8× 73 0.7× 64 0.9× 13 0.3× 23 0.7× 20 242
Tabrez Jafar India 11 56 0.4× 52 0.5× 80 1.1× 22 0.6× 13 0.4× 22 369
Huijuan Zheng China 10 207 1.3× 113 1.2× 124 1.7× 8 0.2× 26 0.8× 27 467
Shokouh Shayanpour Iran 8 87 0.5× 117 1.2× 51 0.7× 14 0.3× 9 0.3× 27 328
Seyed H. Farzaneh United States 9 249 1.6× 108 1.1× 125 1.7× 7 0.2× 19 0.6× 12 466
Xuefei Jiao China 6 290 1.8× 25 0.3× 173 2.4× 10 0.3× 17 0.5× 13 479
Jingai Fang China 9 93 0.6× 95 1.0× 19 0.3× 31 0.8× 4 0.1× 24 316
Yanwei Xing China 4 254 1.6× 25 0.3× 125 1.7× 21 0.5× 21 0.7× 7 386

Countries citing papers authored by Chuan Zou

Since Specialization
Citations

This map shows the geographic impact of Chuan Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Zou more than expected).

Fields of papers citing papers by Chuan Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuan Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Zou. The network helps show where Chuan Zou may publish in the future.

Co-authorship network of co-authors of Chuan Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Zou. A scholar is included among the top collaborators of Chuan Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Zou. Chuan Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zeng, Huan, Qizhan Lin, Fuhua Lu, et al.. (2023). Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study. BMC Nephrology. 24(1). 262–262. 3 indexed citations
3.
Lu, Fuhua, Zhaoyu Lu, Lijuan Han, et al.. (2022). Rhubarb Enema Increasing Short‐Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis. BioMed Research International. 2022(1). 1896781–1896781. 19 indexed citations
4.
Liu, Yongfang, Yizhen Chen, Xiaodan Huang, et al.. (2022). Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning. PLoS ONE. 17(3). e0265017–e0265017. 3 indexed citations
5.
Zhang, Simeng, Liang Hu, Zhang La, et al.. (2022). Metagenomics-based systematic analysis reveals that gut microbiota Gd-IgA1-associated enzymes may play a key role in IgA nephropathy. Frontiers in Molecular Biosciences. 9. 970723–970723. 9 indexed citations
6.
Zeng, Jiahao, et al.. (2021). Plaque control alleviated renal damage that was aggravated by experimental periodontitis in obese rats. Oral Diseases. 28(4). 1228–1239. 7 indexed citations
7.
Huang, Xiaodan, Yizhen Chen, Qizhan Lin, et al.. (2021). The role of urine IgG in the progression of IgA nephropathy with a high proportion of global glomerulosclerosis. International Urology and Nephrology. 54(2). 323–330. 2 indexed citations
8.
Lu, Fuhua, Lixin Wang, Qizhan Lin, et al.. (2021). Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology. American Journal of Nephrology. 52(6). 507–518. 5 indexed citations
9.
Yin, Li, Zhaoyu Lu, Fuhua Lu, et al.. (2021). Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats. Frontiers in Pharmacology. 12. 780924–780924. 31 indexed citations
10.
Lu, Zhaoyu, et al.. (2020). Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification. Frontiers in Pharmacology. 11. 1092–1092. 59 indexed citations
11.
Lu, Zhaoyu, et al.. (2020). The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?. Frontiers in Cell and Developmental Biology. 8. 589752–589752. 22 indexed citations
12.
Zou, Chuan, et al.. (2018). Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress. BMC Pharmacology and Toxicology. 19(1). 53–53. 27 indexed citations
13.
Fan, Ping, Jianmin Song, Qun Chen, et al.. (2018). The influence of environmental factors on clinical pathological changes of patients with immunoglobulin A nephropathy from different areas of China. Renal Failure. 40(1). 597–602. 6 indexed citations
14.
Wang, Yu, et al.. (2017). Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model. Evidence-based Complementary and Alternative Medicine. 2017(1). 2697560–2697560. 8 indexed citations
15.
Zeng, Yuqun, Zhenhua Dai, Fuhua Lu, et al.. (2016). Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease. Oncotarget. 7(14). 17468–17478. 54 indexed citations
17.
Zou, Chuan, et al.. (2015). Modeling and Simulation of Ship Fuel Supply Unit. 199–202. 2 indexed citations
18.
Zou, Chuan, et al.. (2015). [BMP2/BMP4 genetic evaluation in 40 patients with tooth agenesis].. PubMed. 24(1). 83–8. 3 indexed citations
20.
Zou, Chuan, et al.. (2013). Astragalusin the Prevention of Upper Respiratory Tract Infection in Children with Nephrotic Syndrome: Evidence-Based Clinical Practice. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026